1 / 29

Ontario Health System Funding Reform: Overview

Ontario Health System Funding Reform: Overview . Presentation by: Irene Blais, Director, Funding Unit Date: Wednesday September 11 th , 2013 CAPCA – Chief Operating Officer Roundtable. Agenda. Health System Funding Reform and CCO’s Role Current QBPs Systemic Treatment GI Endoscopy

pembroke
Télécharger la présentation

Ontario Health System Funding Reform: Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ontario Health System Funding Reform:Overview Presentation by: Irene Blais, Director, Funding Unit Date: Wednesday September 11th, 2013 CAPCA – Chief Operating Officer Roundtable

  2. Agenda • Health System Funding Reform and CCO’s Role • Current QBPs • Systemic Treatment • GI Endoscopy • New QBPs • Cancer Surgery • Colposcopy • Q & A

  3. Health System Funding Reform and CCO’s Role

  4. Health Service Providers (e.g. Community Care Access Centres, Hospitals) What is Health System Funding Reform Vision? HSFR Global Funding • Evidence-based funding driven based on the highest quality, most efficient care • How many patients they look after • The services they deliver • The evidence-based quality of these services • The specific needs of the population they serve Slide provided by MOHLTC

  5. Funding Reform: Two Key Components • Health Based Allocation Model (HBAM) • HBAM is a made-in-Ontario model that informs funding allocation to health services providers based on population needs • Quality-Based Procedures (QBP) • Price x volume, evidence based clinical pathways ensure quality standards • Opportunity for process improvements, clinical re-design, improved patient outcomes, enhanced patient experience

  6. HSFR: The model

  7. Recap: An evidence and quality-based framework has identified Quality-Based Procedures that have the potential to both improve quality outcomes and reduce costs

  8. 2013/14 Funding Allocation Update Slide provided by MOHLTC

  9. CCO/ORN leading full implementation of Quality-Based Procedures including… Products Product Details Clinical • Quality-Based Procedures’ Definitions • Best Practices • Better Practice Hospitals • Clinical Handbooks • Clinical Engagement Pricing/ Funding • Quality-Based Procedure Best Practice Price • Quality Overlay Framework Capacity Planning • Regional/System Volume Management/Capacity Planning Strategy • Capacity Utilization and Forecasting Program Monitoring and Evaluation • Integrated Quality-Based Procedure Scorecard 9

  10. Why is CCO part of HSFR? • Government’s Advisor for Cancer & Renal Services. • Principles of equity, evidence-based recommendations, performance-oriented goals, and value for money (help build the best health system in the world) • Motivate change through the cause, evidence and data, and funding levers • Oversee more than $800 million in patient-based funding • Robust clinical leadership model based on regional networks • Well-developed evidence review and guideline development processes • Well-developed performance management model

  11. Current QBPs – Systemic Treatment

  12. Why Reform Systemic Therapy? Limitations of the Current Model • Systemic Treatment if funded in a variety of ways: • RCCs: Lifetime payment triggered by a consultation (C1S) • Non-RCCs: Per case (unique patient) or funding per visit in some cases • Some facilities receive PCOP funding (per visit) • This results in: • Inequities: Not all hospitals receive funding for systemic treatment • Duplication: In some cases, double-payment exists Further treatment Funding Provided Treatment start Consult $3400 Patient does NOT require treatment RCC $3400 RCC RCC RCC RCC RCC RCC $3400 + $3300 Community Hospital RCC RCC

  13. How will the new funding model address these limitations? • Move from a lifetime payment approach to an activity-based bundled payment approach • A Bundled payment approach allows funding to follow the patient, thereby: • Recognizing incident and prevalent cases • Particularly important as survivorship improves • Reducing & eventually eliminating inequities in funding • Supporting the shared care model (resulting from a consistent/fair funding model) • Recognizing the work associated with the delivery of oral chemotherapy regimens • Incent for high-quality care: • Identifying and funding for appropriate care according to evidence-informed practice • Ensuring patients get access to care they need • Optimizing use of resources Developing a new funding model for systemic treatment is a priority for CCO under the RSTP Provincial Plan released in 2009

  14. The Bundled Payment Model- Phased Approach Treatment/ Follow-up Consultation Parenteral Treatment- Adjuvant, Curative, Neo-Adjuvant Developed & undergoing validation, 2014-15 implementation Consultation for Systemic Treatment Developed and to be implemented 2014/15 • Diagnosis/ Staging Bundle • For future phase development & implementation • Other treatment bundles: • - Parenteral Treatment-Palliative • Oral Treatment (may be multiple bundles) • To be developed for 2014-15 implementation Follow-up (may be multiple bundles) To be developed for 2014-15 implementation Move from a lifetime payment approach to funding for specific bundles of activity to funding that follows the patient

  15. Validating Evidence- Informed Practice Next Steps: Incorporate feedback from all DSG Member Review(where appropriate) All Practitioner Review (fall 2013)

  16. Current QBPs – GI Endoscopy

  17. Scope of GI Endoscopy QBP • GI Endoscopy Activity in Hospitals (517,788 cases in 2011/12) • Colonoscopy Inspection procedures • Gastroscopy Inspection procedures • Excision/Biopsy/Destruction procedures • Other GI Endoscopy: ex. EUS, ERCP and Laser procedures • Hospital Care Setting • Endoscopy suite • Day Surgery Room • Inpatient • Emergency Room • Expenses • $139M in hospital direct costs (2011/12) • Pathology laboratory is out-of-scope • Physician fees are out-of-scope

  18. Scope of GI Endoscopy QBP • Evidence gathered during QBP development suggests that the colonoscopy QBP should be expanded to include all endoscopy services: • Better patient care when multiple interventions are required • Many services performed in the endoscopy suite, and the associated resources, cannot be decoupled • The quality agenda for colonoscopy and endoscopy are tightly aligned • Economies of scale exist when multiple endoscopy services are preformed together • Overlap of funding across the breadth of services provided in an endoscopy suite is substantial

  19. Scope of GI Endoscopy QBP • The table above summarizes the number of G.I Endoscopy procedures by procedure combination in each of the 4 identified settings in 2011/12. • The 11 procedure combinations are mutually exclusive meaning that a patient encounter can only be mapped to one combination. • The total expenses for these procedures are estimated at $139MM based on 2011/12 data

  20. New QBPs – Cancer Surgery

  21. Cancer Surgery Agreements (CSA) to… Quality Based Funding (QBP) • CCO has been advising the Ministry of Health and Long-Term Care on the allocation of incremental funding for cancer surgery procedures since 2004 • Good progress – decrease in wait times • Strong linkage to quality via Schedule B • Cancer Surgery is well positioned for transition to QBP • Strong quality program & guidelines & pathways • Benefit from knowledge gained from CSA process & methodology • Disease site approach • Prostate will be the initial disease site • Unknown – possible that CSA will exist for some disease sites

  22. Annual Cancer Surgery Volumes 2004/05 – 2012/13 (incremental funding $70MM 2012/13)

  23. Cancer Surgery Wait times

  24. New QBPs – Colposcopy

  25. Current State - Colposcopy • In Ontario, colposcopies are conducted both in hospitals and also within the community, primarily private practitioner offices and clinics. • Based on clinical expert feedback at CCO, variations in practice exist in all settings across the province of Ontario. • In addition, a consistent, system-wide approach for accountability over the quality and efficacy of colposcopy services provided does not exist. • The 2008 Program In Evidence-Based Care (PEBC) Colposcopy standards (which describe the optimum organization for the delivery of colposcopy services in Ontario) are currently in the process of being revised.

  26. Current State - Colposcopy • CCO foresees the need to include both hospitals and community settings in order to appropriately apply these standards across the province of Ontario. • Practice variations, as well as the lack of consistent mechanisms for measuring quality, each present an opportunity to increase quality and efficiency across the system by including both hospitals and community settings in the definition of the Colposcopy QBP. • The Colposcopy QBP aims to improve quality, decrease wait times and reduce lost-to-follow-up rates.

  27. Current State - Colposcopy

  28. Next Steps – Policy and Strategy • Continued Policy and Strategy development including but not limited to: • Cancer funding ‘Think Tank’ • Funding across multiple sectors including homecare • Models of Care • Environmental scan • Evaluation framework

More Related